Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes
Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received April 3, 2017
- Accepted July 13, 2018
- Published online ahead of print August 21, 2018.
Article Versions
- You are currently viewing a Previous version of this article (August 21, 2018 - 09:53).
- View the most recent version of this article
Copyright & Usage
© 2018 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
Author Information
- Urvi Desai1⇑,
- Noam Y. Kirson1,
- Jennifer Kim2,
- Kamlesh Khunti3,
- Sarah King1,
- Erich Trieschman1,
- Michael Hellstern1,
- Phillip R. Hunt4 and
- Jayanti Mukherjee5
- 1Analysis Group, Inc., Boston, MA
- 2AstraZeneca, Gaithersburg, MD
- 3Diabetes Research Centre, University of Leicester, Leicester, U.K.
- 4Evidera, Waltham, MA
- 5Bristol-Myers Squibb, Wallingford, CT
- Corresponding author: Urvi Desai, urvi.desai{at}analysisgroup.com.
Statistics from Altmetric.com
Article usage
Current Issue
December 2019
Volume 42, Issue 12
Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes
